End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy
- PMID: 20185429
- DOI: 10.1093/eurjhf/hfq020
End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy
Abstract
Aims: A left ventricular end-systolic volume (LVESV) > or =60 mL/m(2) has been shown to be associated with increased cardiac mortality after a reperfused myocardial infarction (MI). The reduction in LVESV following surgical ventricular reconstruction (SVR) is reported to be between 19% and 50% but its impact on prognosis is not well-established. The aim of this study was therefore to assess the impact on survival of a residual LVESV index (LVESVI) of > or = or <60 mL/m(2) following SVR.
Methods and results: All patients undergoing SVR at our Centre between July 2001 and March 2009 were eligible to be included in this study if they had a preoperative LVESVI of > or =60 mL/m(2) and an LVESVI measurement performed at discharge (7-10 days after surgery). Two hundred and sixteen patients (aged 64 +/- 9 years, 33 women) satisfied these criteria. Coronary artery bypass graft was performed in 197 patients (91.2%) and mitral repair in 63 patients (29%). Left ventricular ESVI had decreased by 41% at discharge in the overall population. Patients were grouped according to the residual LVESVI at discharge as follows: Group 1, LVESVI > or = 60 mL/m(2) (n = 71), and Group 2, LVESVI < 60 mL/m(2) (n = 145). In both groups, LVESVI decreased significantly with respect to baseline, by 29% in Group 1 and by 47% in Group 2. At multivariate analysis, the presence of a non-Q-wave MI and a preoperative internal diastolic diameter of 65 mm were the strongest predictors of a residual post-operative LVESVI of > or =60 mL/m(2). Risk of all-cause death was significantly higher in Group 1. Post-operative LVESVI of > or =60 mL/m(2) was an independent predictor of mortality at follow-up [Exp(B) = 10.7, CI: 2.67-42.9, P = 0.001].
Conclusion: Our findings confirm the role of LVESVI in predicting survival following SVR; the lack of additional improvement in survival with SVR observed in the STICH trial might be due to the inadequate volume reduction (-19%).
Similar articles
-
Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival.Eur J Heart Fail. 2014 Feb;16(2):189-200. doi: 10.1002/ejhf.24. Epub 2013 Dec 9. Eur J Heart Fail. 2014. PMID: 24464828
-
Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.Eur J Cardiothorac Surg. 2009 Jun;35(6):995-1003; discussion 1003. doi: 10.1016/j.ejcts.2008.11.007. Epub 2009 Jan 10. Eur J Cardiothorac Surg. 2009. PMID: 19136274
-
Ventricular volume and myocardial viability, evaluated using cardiac magnetic resonance imaging, affect long-term results after surgical ventricular reconstruction.Eur J Cardiothorac Surg. 2016 Oct;50(4):704-712. doi: 10.1093/ejcts/ezw213. Epub 2016 Jun 28. Eur J Cardiothorac Surg. 2016. PMID: 27354255
-
Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy.Ann Thorac Surg. 2005 Feb;79(2):456-61. doi: 10.1016/j.athoracsur.2004.07.045. Ann Thorac Surg. 2005. PMID: 15680814 Clinical Trial.
-
Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy.Eur J Cardiothorac Surg. 2010 May;37(5):1093-100. doi: 10.1016/j.ejcts.2009.12.006. Epub 2010 Jan 8. Eur J Cardiothorac Surg. 2010. PMID: 20060737
Cited by
-
Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction.Curr Treat Options Cardiovasc Med. 2016 Sep;18(9):57. doi: 10.1007/s11936-016-0479-1. Curr Treat Options Cardiovasc Med. 2016. PMID: 27488313 Review.
-
Surgical options for the management of ischemic cardiomyopathy.Curr Treat Options Cardiovasc Med. 2013 Oct;15(5):518-32. doi: 10.1007/s11936-013-0261-6. Curr Treat Options Cardiovasc Med. 2013. PMID: 24018769
-
Surgical ventricular restoration: where do we go from here?Heart Fail Rev. 2015 Jan;20(1):89-93. doi: 10.1007/s10741-014-9433-z. Heart Fail Rev. 2015. PMID: 24833317 Review.
-
Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients.Ann Cardiothorac Surg. 2022 May;11(3):226-238. doi: 10.21037/acs-2021-ami-17. Ann Cardiothorac Surg. 2022. PMID: 35733719 Free PMC article.
-
A Modified Surgical Ventricular Reconstruction in Post-infarction Mice Persistently Alleviates Heart Failure and Improves Cardiac Regeneration.Front Cardiovasc Med. 2021 Dec 24;8:789493. doi: 10.3389/fcvm.2021.789493. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 35004900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources